PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsBreast cancer gene raises lung cancer risk in smokers

BioNews

Breast cancer gene raises lung cancer risk in smokers

Published 6 June 2014 posted in News and appears in BioNews 757

Author

Dr Molly Godfrey

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Smokers are more likely to develop lung cancer if they carry a defective version of a gene associated with breast cancer, a study has found...

Smokers are
more likely to develop lung cancer if they carry a defective version of a gene
associated with breast cancer, a study has found.

Mutations
in the BRCA2 gene have long been linked to increased risk of developing breast,ovarian and prostate cancers. Now, researchers have found that that a specific variant of the gene also increases the risk of lung cancer, particularly in smokers. Lifetime
risk for developing lung cancer for smokers, normally at around 13 percent, rises
to 25 percent for those that possess the defective gene.

This
means that smokers with this mutant BRCA2 have a one in four chance of developing
cancer — almost double the risk of those who don't smoke. The mutant gene is
present in about two percent of the population, so given that there are 10
million adult smokers in the UK, the researchers estimate that up to 200,000
people could be affected.

'Our
study showed that mutations to [BRCA2] have a very large effect on lung cancer
risk in the context of smoking', said Professor Richard Houlston from the Institute
of Cancer Research in the UK, one of the lead researchers. 'Some smokers with
BRCA2 mutations are at an enormous risk of lung cancer — somewhere in the
region of 25 percent over their lifetime', he added.

In the study, published in Nature
Genetics, the researchers compared the DNA of over
11,000 lung cancer patients with that of almost 16,000 healthy controls, all of
European ancestry, and looked for differences between the two groups. They
found that the variant of BRCA2 known as c.9976T was more common in the
patients with lung cancer than without, particularly in squamous cell lung
cancer, the most common lung cancer type.

It is
thought that mutant BRCA2 can no longer properly repair damaged DNA caused by
smoking. 'In the context of smoking there is such an enormous amount of DNA
damage that any loss of DNA repair is going to be an issue', Professor Houlston told BBC News.

Specific drugs for breast or ovarian cancer patients with BRCA2 mutations are
in development and have already shown promising results in clinical trials.
This raises the possibility that these drugs, called PARP
inhibitors, may also work in lung cancer patients with mutant BRCA2. However,
this is only speculative, as whether the drugs will actually work against lung
cancer is not known.

This
study confirms that there is an inherited genetic susceptibility to lung
cancer. Professor Paul Workman, from the Institute of Cancer Research, said: 'All
smokers are taking a considerable risk with their health, regardless of their genetic
profile, but the odds are stacked even more heavily against those with this
genetic defect who smoke'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 September 2015 • 3 minutes read

UK Biobank data reveals new associations between smoking and lung cancer

by Dr Antony Starza-Allen

Health and genetic data from the UK Biobank has revealed new genetic associations between smoking and lung cancer, including five areas of DNA for the first time associated with heavy smoking.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 September 2014 • 2 minutes read

Prototype lung cancer breath test checks for gene mutations

by Dr Antony Starza-Allen

Scientists have shown that minimal genetic changes can be detected in vapour containing cells engineered to replicate early stage lung cancer....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 August 2014 • 3 minutes read

Epigenetic 'switches' could cause cancer

by Daryl Ramai

Scientists at the Children's Nutrition Research Center, USA have shown that epigenetic changes alone could cause cancer....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 June 2014 • 2 minutes read

Test for genetic switches could predict breast cancer risk

by Dr Nicoletta Charolidi

A simple blood test that can predict the likelihood of developing non-inherited breast cancer could be developed, following research into the epigenetics of the disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
16 May 2014 • 2 minutes read

Drug targeting untreatable lung cancer 'shrinks tumours'

by Dr Antony Starza-Allen

British pharmaceutical company AstraZeneca has presented trial data from an experimental lung cancer drug...

Image by Christoph Bock/Max Planck Institute for Informatics via Wikimedia Commons. Depicts a DNA molecule that is methylated on both strands on the centre cytosine.
CC BY-SA 3.0
Image by Christoph Bock/Max Planck Institute for Informatics via Wikimedia Commons. Depicts a DNA molecule that is methylated on both strands on the centre cytosine.
News
7 April 2014 • 2 minutes read

Men who smoked before teens may father fatter sons

by Dr Kimberley Bryon-Dodd

Smoking before puberty may lead to men fathering fatter sons, suggesting that lifestyle factors can have adverse impacts on the next generation, a study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2013 • 2 minutes read

Breast cancer risk may still be higher despite BRCA-negative test results

by Dr Charlotte Warren-Gash

Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 November 2013 • 2 minutes read

Lung cancer genetics moves forward

by Dr Sarah West

Two recent studies have shown how treatments for lung cancer can be tailored to a tumour's genetic make-up, which may ultimately improve existing treatments or even help to identify new ones...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Mitochondrial replacement likely to be safe but more research needed, says report

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Common virus may be cause of recent hepatitis cases in children

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

1 August 2022 • 2 minutes read

CRISPR genome editing treatments may raise cancer risk

1 August 2022 • 2 minutes read

Differences in IVF-conceived children's size disappear by adolescence

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856